BiotechTube

Equfina

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Parkinson Disease

Conditions

Parkinson Disease

Trial Timeline

Oct 14, 2020 → Oct 13, 2022

NCT ID
NCT04724109

About Equfina

Equfina is a pre-clinical stage product being developed by Eisai for Parkinson Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT04724109. Target conditions include Parkinson Disease.

What happened to similar drugs?

20 of 20 similar drugs in Parkinson Disease were approved

Approved (20) Terminated (3) Active (0)
✅Mirabegron + PlaceboAstellas PharmaApproved
✅Lemborexant + placeboEisaiApproved
✅Safinamide MesilateEisaiApproved
✅Istradefylline PillKyowa KirinApproved
✅Levodopa-carbidopa intestinal gel (LCIG)AbbVieApproved
✅Carbidopa/levodopa/entacaponeNovartisApproved
✅Carbidopa/levodopa/entacapone + Immediate release carbidopa/levodopaNovartisApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT04724109Pre-clinicalCompleted

Competing Products

20 competing products in Parkinson Disease

See all competitors
ProductCompanyStageHype Score
exidavnemab + Placebo ComparatorBioArctic ABPhase 2
36
UB-312 + PlaceboVaxxinityPhase 1
19
NAV5001 + DaTscanNavidea BiopharmaceuticalsPhase 3
22
LY4006896 + PlaceboEli LillyPhase 1
36
ATH-1017 + PlaceboLeonaBioPhase 2
17
piclozotan + 0.9% sodium chloride (normal saline)Daiichi SankyoPhase 2
35
Mirabegron + PlaceboAstellas PharmaApproved
43
E2007EisaiPhase 3
32
ARICEPTEisaiPhase 3
40
PerampanelEisaiPhase 3
32
GPI 1485EisaiPhase 2
35
E2007EisaiPhase 3
40
Prior Donepezil 5mg + Prior Donzepezil 10mg + Prior PlaceboEisaiPhase 3
40
Equfina 50 mgEisaiPre-clinical
26
perampanel + placeboEisaiPhase 2
27
Lemborexant + placeboEisaiApproved
50
Placebo + E2007 + E2007EisaiPhase 3
32
Safinamide MesilateEisaiApproved
43
E2007 + E2007 + E2007EisaiPhase 2
35
E2007EisaiPhase 2
35